Vical Inc (VICL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Vical Inc (Vical) is a biopharmaceutical company, which focuses on research and development on DNA delivery technologies for the prevention and treatment of life-threatening diseases and vaccines for infectious diseases and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. Vaxfectin adjuvant is a proprietary cationic lipid-based formulation it is a protein--based vaccines. The companys DNA delivery technology takes up polynucleotide genetic material, such as DNA or RNA. The company has collaborations with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. Vical is headquartered in San Diego, California, the US.

Vical Inc (VICL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Vical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vical Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Vical Enters into Partnership with Mycoses Study Group Education & Research Consortium 10
Vical Enters into Agreement with AnGes to Develop and Commercialize Equine Polyclonal Antibody Therapy 11
Licensing Agreements 12
Vical Enters into Licensing Agreement with Astellas Pharma for ASP2397 12
Vical Enters Into Licensing Agreement With Cyvax For Vaxfectin Adjuvant 14
Bristol-Myers Squibb Enters Into Licensing Agreement With Vical For Antibodies 15
Equity Offering 16
Vical Prices USD25 Million in Public Offering of Shares 16
Vical Raises up to USD7.8 Million in Private Placement of Shares 17
Vical Announces Public Offering Of Common Stock For Up To US$50 Million 18
Vical, Biopharma Company, Completes Public Offering Of Common Stock For US$52.2 Million 19
Vical Inc - Key Competitors 21
Vical Inc - Key Employees 22
Vical Inc - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
May 03, 2018: Vical Reports First Quarter 2018 Financial and Operational Results 24
Mar 15, 2018: Vical Reports Fourth Quarter 2017 Financial and Operational Results 25
Oct 23, 2017: Vical Reports Third Quarter 2017 Financial and Operational Results 26
Aug 08, 2017: Vical Reports Second Quarter 2017 Financial and Operational Results 27
May 15, 2017: Vical Reports First Quarter 2017 Financial Results 28
Mar 09, 2017: Vical Reports Fourth Quarter 2016 Financial Results 29
Government and Public Interest 30
Jan 29, 2018: Motif Bio, Spero Therapeutics and Vical Join Antimicrobials Working Group 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List Of Tables

List of Tables
Vical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Vical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vical Enters into Partnership with Mycoses Study Group Education & Research Consortium 10
Vical Enters into Agreement with AnGes to Develop and Commercialize Equine Polyclonal Antibody Therapy 11
Vical Enters into Licensing Agreement with Astellas Pharma for ASP2397 12
Vical Enters Into Licensing Agreement With Cyvax For Vaxfectin Adjuvant 14
Bristol-Myers Squibb Enters Into Licensing Agreement With Vical For Antibodies 15
Vical Prices USD25 Million in Public Offering of Shares 16
Vical Raises up to USD7.8 Million in Private Placement of Shares 17
Vical Announces Public Offering Of Common Stock For Up To US$50 Million 18
Vical, Biopharma Company, Completes Public Offering Of Common Stock For US$52.2 Million 19
Vical Inc, Key Competitors 21
Vical Inc, Key Employees 22

List Of Figures

List of Figures
Vical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Vical Inc (VICL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Vical Inc (Vical) is a biopharmaceutical company, which focuses on research and development on DNA delivery technologies for the prevention and treatment of life-threatening diseases and vaccines for infectious diseases

USD 250 View Report

Vical Inc (VICL) - Financial and Strategic SWOT Analysis Review

Vical Inc (VICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

Vical Inc (VICL) - Financial and Strategic SWOT Analysis Review

Vical Inc (VICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

Vical Incorporated Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Vical Incorporated Company Profile is a detailed strategic and analytical report on Vical Incorporated. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available